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Risk factors for the development of osteoporosis in a
South African population
A prospective analysis
R. BLAAUW, E. C. ALBERTSE, T. BENEKE, C. J. LOMBARD, R. LAUBSCHER,
F.S.HOUGH
Abstract Despite the vast number of risk factors that appa-
rently predispose to the development ofosteoporo-
sis (OP), they have not been accurately identified
and given relative priority. In order to analyse
possible risk factors prospectively in a local
patient population with overt OP (histOInorpho-
metrically confirmed and characterised) and com-
pare it with an appropriately matched non-OP
control group (with normal bone mass on dual-
energy X-ray absorptiometry), a detailed general
history, risk factor analysis, dietary history and
anthropometric data were obtained from 56 OP
and 125 non-OP subjects. In females a positive
family history ofOP (P =0,002), a fair complexion
(P =0,009), lower body mass (P =0,02) and height
(P =0,03), no breast-feeding of babies (P =0,006),
a history of smoking (P = 0,001) and fat distribu-
tion around the waist (P =0,009) were identified as
risk factors. In males lack of exercise (P =0,008), a
history of smoking (P =0,01), lower body mass
(P = 0,04) and height (P = 0,04), a preference for
salty· food (P =0,02) and fat distribution around
the waist (P =0,002) appeared to predispose.
Dietary calcium, phosphorus, protein and caffeine
intakes were similar in OP and control subjects,
but alcohol consumption was clearly higher in
both OP males (P = 0,001) and females (P = 0,01).
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O steoporosis (OP) and associated fractures areendemic in Western societies, with prevalencerates approximating 50% among elderly white
women, a mortality rate of 12 - 25% in patients with hip
fractures, and annual costs of some $7 billion in the
USA alone. 1 Although it clearly constitutes a major
health problem, the exact incidence and magnitude of
the OP syndrome in South Africa is as yet unknown.
Since OP usually becomes manifest at a late stage
when the patient has lost more than 50% of his/her
skeletal mass, early detection and imp1ementation of
prophylactic measures are essential. This is, however,
complicated by the fact that bone loss is undetectable by
routine radiographs until at least 30 - 40% of the bone
mass has been lost. Moreover, the more reliable and
accurate methods of measuring bone mass, such as
dual-energy X-ray absorptiometry (DEXA), are expen-
sive and not readily available.2 Ideally, the identification
of historical risk factors of a person's predisposition to
develop OP, followed by DEXA examination of those at
risk, should be undertaken.
Although a large number of possible risk factors for
the development of OP are known, studies to date have
generally been unsuccessful in identifying and giving
relative priority to those risk factors that are most impor-
tant in a specific community. Moreover, since OP is a
heterogeneous syndrome and not a single disease entity,
different risk factors may pertain to different subsets of
OP.
This study aimed to analyse possible risk factors
prospectively in a local patient population with overt
primary OP and to compare it with an appropriately
matched non-OP control group_
Subjects and methods
Subjects
All the subjects in the OP group had proven idiopathic
('primary') OP, detected by DEXA as well as clinical
examination, a skeletal survey, quantitative histomor-
phometric examination of undeca1cified bone biopsies
and a full biochemical work-up. The group consisted of
56 subjects, consecutively admirted to our metabolic
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unit, of whom 17 were male and 39 female. The mean
age (± SD) of the males was 49 ± 1.5 years and that of
the females 61 ± 11 years.
Absence of osteopenia in the control group was con-
firmed by DEXA. TIJis group consisted of 125 age- and
sex-matched subjects of whom 27 were males and 98
females. The mean age of the males was 52 ± 16 years
and that of the females 60 ± 10 years. All the subjects
were white and resided in the Cape Province.
Methods
A dietary history was obtained from every subject by
means of a quantified food frequency questionnaire,
covering current and past intakes. 3 A detailed general
history and a risk factor questionnaire were completed
by all the subjects. Anthropometric data were also
obtained from every subject and included weight,
height, skinfold measurements, mid-upper arm, middle
and hip circumferences and elbow breadth determina-
tion. The following methods were employed: (z) the
subjects were weighed, wearing the minimum of clothes,
to the nearest 0,1 kg;4 (zi) height was measured with a
sliding headpiece to increase the accuracy of the read-
ings, which were taken to the nearest 0, I cm;4 (iiz) skin-
folds were measured using a Harpenden caliper (all
measurements were taken on the right side of the body
to the nearest 0,1 mm, as follows: biceps - over the
biceps muscle, at the midpoint of the muscle; triceps -
over the triceps muscle, midway between the acromial
process of the scapula and the olecranon; subscapular -
just below the tip of the scapula, at 45° to the vertical;
supra-iliac - just above the iliac crest on the mid-axil-
lary line);· (iv) mid-upper arm circumference was
measured at the same position as the triceps skinfold;4
(v) middle circumference was determined in the erect
position, around the waist through a point one-third of
the distance between the xiphoid process and the
umbilicus;' (vz) hip circumference was assessed in the
erect position, around the hips through a point 4 cm
below the superior anterior iliac spine;' and (viz) elbow
breadth was measured with a sliding caliper to the
nearest 0,1 cm, at the point of greatest breadth across
the joint." All the measurements were done by the same
researcher in triplicate, and the results averaged.
Investigation of subjects with OP comprised a physi-
cal examination; urinalysis; a full blood count; a bio-
chemical profile, including serum calcium, phosphate
and alkaline phosphatase (measured with a Technicon
SMAC II AutoAnalyzer), C-terminal parathyroid hor-
mone (radio-irnniunoassay'), cortisol (Clinical Assays,
RIA Kit), "thyroid-stimulating hormone (Serona RIA
Kit) and free thyroxine and free tri-iodothyronine
(Amersham M, RIA Kit); protein electrophoresis; a
radiological skeletal survey; and quantitative histomor-
phometric examination of undecalcified bone biopsy
specimens after time-spaced tetracycline labelling,' to
confirm the diagnosis of primary OP and rule out other
causes of osteopenia and/or secondary OP.
Axial bone mass was measured by DEXA (Hologic
QDR-I000) in all subjects. TIJis included the lumbar
spine (LI-L4) and hip (neck, trochanter, inter-
trochanteric region, Ward's triangle and total). OP was
diagnosed if the bone mineral density" (BMD) was found
to be decreased by more than 1,5 SD in subjects
younger than 40 years, or by more than 2,0 SD in those
over 40 years of age, compared with the BMD of young
normal subjects."
Statistical analysis was performed by means of the
Wilcoxon signed-ranks test, the Spearman correlation
coefficient and the Cochran-Mantel-Haenszel test to
determine odds ratios (ORs) and to obtain 95% confi-
dence intervals (95% Cl) for this statistic"
Results and discussion
Table I sets out the BMD values of the lumbar spine
and hip regions of the OP and the control groups as per-
formed by DEXA. As expected, the values of the OP
men and women were significantly lower than that of
the controls throughout.
Dietary data
In all subjects, not a single nutrient (current and past
intakes) was consumed in quantities less than the
recommended daily allowances (RDA).IO There was also
no significant difference between the intakes of the OP
and the contre; ~,,"·)ups.
The mean calcium intake of all the subjects was ade-
quate compared with the RDA and was comparable in
the two groups. The average intakes of the men ranged
between 810 and 860 mg/d and that of the women
between 800 and 815 mg/d. The RDA of calcium for
adults is set at 800 mg/d in the USA and the RSA. 10
Lindsayll and others I2,13 have shown that lactating or
pregnant premenopausal women and postmenopausal
women need much more calcium Cl 000 - 1 500 mg) to
prevent a negative calcium balance. A negative calcium
balance greater than 40 mg/d will result in bone loss of
1,5% per year. 14
Although severe calcium deprivation causes OP in
animals, and lower fracrure rates have been reported in
areas of high calcium intake, I' the role of dietary calcium
in the causation of OP in humans is still controversial.
Advances have, however, recently been made in unrav-
elling the calcium controversy. It is now accepted that
low calcium intake can definitely limit the achievement
of genetically programmed peak bone mass/·,I' but the
role of dietary calcium in later life is less clear. Before
the menopause oestrogen-replete women are able to
conserve calcium efficiently, and calcium intake at this
time exhibits little relationship to bone mass.
Menopausal bone loss is mainly due to oestrogen with-
drawal and it is now well established that exogenous cal-
cium will not replace endogenous oestrogen in peri- or
postmenopausal subjects. It is not surprising that most
----
TABLE!.
BMO values (glcm2)(mean ± SO) for OP and control subjects
Men Women
Measurements OP Controls Significance OP Controls Significance
Spine
L1-L4 0,72 ± 0,13 1,15 ± 0,13 p= 0,0078 0,72±0,10 1,11 ±0,17 p= 0,0001
Hip
Neck 0,64 ± 0,12 0,95 ± 0,08 p= 0,0078 0,60 ± 0,09 0,88 ± 0,13 p= 0,0001
Troch. 0,54 ± 0,08 0,80 ± 0,06 p= 0,0078 0,50 ± 0,10 0,76 ± 0,09 p= 0,0001
Total 0,74±0,12 1,09 ± 0,06 p= 0,0078 0,64 ± 0,20 1,02 ± 0,13 p= 0,0001
Ward's 0,39 ± 0,16 0,69±0,10 p= 0,0078 0,39 ± 0,11 0,71 ± 0,17 p= 0,0001
FIG. 1.
Alcohol intake of OP v. control subjects.
Anthropometric data
Short individuals are at risk (less total bone) and thin
subjects, including those with a low skinfold thickness,
are at even greater risk of developing OP fractures -
observations that have been ascribed to decreased
peripheral conversion of circulating androgens to oestro-
gens by adipose tissue and to less mechanicalloading.30,28
Table IT depicts all the anthropometric data of the sub-
jects. The OP men and women were significantly (P =
0,04) shorter and of a lower body mass than controls.
The OP group also had significantly lower elbow
breadth values (an indicator of frame size) than the con-
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Marked differences were found between the alcohol
consumption of both OP males (P = 0,001) and OP
females (P =0,01) when compared with matched con-
trols in the present srudy (Fig. 1). Numerous srudies
have reported that excessive use of alcohol results in
bone loss and an increased incidence of fracrures. 26,27
Alcohol has a direct toxic effect on osteoblasts and sup-
presses bone formation. 28 It may also promote bone loss
as a consequence of poor nutrition,"" malabsorption,29
liver damage,"" alcohol-induced calcium diuresis,'"
reduced physical activity and body weight,'O and/or
hypercortisolaemia. 31 Regular use of alcohol may also
increase the fracture rate by predisposing to falls.
Kelseyi found that the risk for hip fractures doubled if
more than 8 tots of alcohol were consumed per week -
an amount that was grossly exceeded by both OP men
(21 tots) and OP women (12 tots) in the present srudy.
of the negative studies of calcium intake relative to age-
related bone loss have in fact been performed during
this early menopausal period. Conversely, most of the
positive studies on calcium intake and bone loss have
concentrated on older postmenopausal women. A
definitive large-scale study by Dawson-Hughes et al.'8
has demonstrated that calcium supplementation
improves bone mass in older women (> 6 years post-
menopausal) with a dietary intake under 400 mg/d.
Similar results were reported by others. 19,20 It is also
important to note that the absorption and bio-availabi-
lity of calcium is markedly influenced by other dietary
constituents (including phosphorus, protein, sodium,
fibre, phyrates), calciotropic and sex hormones, lactose
intolerance and local factors in the gut."
An increased protein intake results in hypercalciuria
and a negative calcium balance." The calciuric effect of
protein is, however, diminished if the protein source is
also high in phosphorus, e.g. meat." It is therefore diffi-
cult to assess whether a high protein intake per se should
be regarded as a risk factor for OP, since diets contain-
ing protein also contain other nutrients, making it
impossible to determine the effect of protein alone. 1 In
the present study, protein and phosphorus intakes were
similar in OP and control subjects, where the men aver-
aged 95 g and 1 500 mg respectively and the women
75 g and 1 250 mg. These values compare favourably
with RDA recommendations. lO
Zarkadas et al. 22 have shown that as little as 3 g
sodium cWoride results in a significant rise in urinary
calcium excretion in ~Qstmenopausalwomen. An
increased sodium intake was also shown to increase
parathyroid hormone secretion and bone resorption.
Although it has been suggested23 that a significant
amount of postmenopausal bone resorption may be
sodium-dependent and may respond to dietary salt
restriction, further studies are required. In our study,
the OP males had a significantly (P = 0,02) greater incli-
nation towards salty food than control males, with the
chance of an OP male adding extra salt to his food being
4,7 times that of a control male (95% Cl: 1,252 -
17,857). No significant difference was found between
the women.
Heaney and Recker24 recently reported that a high
caffeine intake (especially> 1 gld) results in a negative
calcium balance as a consequence of increased urinary
calcium 10sses. 24 Other studies have failed to support
these observations.' The mean per capita intake of caf-
feine in the USA is estimated at 200 mg/d, equivalent to
approximately 2 cups of coffee per day.25 The mean
intake in this study ranged from 360 to 420 mg/d,
equivalent to 4 - 5 cups of coffee per day. There was,
however, no significant difference between the caffeine
intakes of OP and control subjects.
TABLE 11.
Anthropometric data (mean ± SO) for OP and control subjects
Men Women
Measurements OP Controls Significance OP Controls Significance
Body mass (kg) 70 ± 12 77± 12 p= 0,04 64± 12 69± 12 p= 0,02
Height (cm) 1,71 ± 0,07 1,77±O,08 p= 0,04 1,62 ± 0,06 1,64 ± 0,07 p= 0,03
Elbow breadth (cm) 7,1 ± 0,3 7,4 ± 0,4 p= 0,007 6,4 ± 0,8 6,7 ± 0,4 p= 0,03
Biceps (mm) 5,6 ± 2,9 6,5 ± 2,5 p= 0,10 12,0 ± 5,7 12,6 ± 5,9 p= 0,69
Triceps (mm) 10,7 ± 5,3 13,2 ± 2,9 p= 0,01 20,0 ± 6,4 23,4 ± 6,3 p= 0,01
Subscapular (mm) 12,3 ± 4,6 16,4 ± 6,4 p= 0,03 16,3 ± 6,7 16,8 ± 7,1 p= 0,96
Supra-iliac (mm) 13,1 ± 5,5 16,6 ± 5,3 p= 0,07 18,2 ± 8,5 19,9 ± 9,0 p= 0,52
Mid-upper arm 29,2 ± 2,0 31,4 ± 3,0 p= 0,008 29,0 ± 4,3 31,1±3,6 p= 0,0005
circumf. (cm)
Middle circumf. (cm) 85,6 12,2 90,9 ± 9,6 p= 0,18 84,9 ± 15,3 83,9 ± 10,7 p= 0,91
Hip circumf. (cm) 89,3 12,3 100,9 ± 6,5 p= 0,001 97,9 ± 13,4 103,9 ± 10,3 p= 0,01
WHR 0,96 0,06 0,89 ± 0,06 p= 0,002 0,87 ± 0,11 0,81 ± 0,05 p= 0,0009
WHR = waist-to-hip ratio.
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trois, although mean values for both groups fell in the
range of medium frame size. The OP group had signifi-
cantly lower skinfold and circumference values for most
of the measurements, although the majority of subjects
in both groups fell within the 15 - 85th percentile.
An increased risk for the development of chronic
degenerative diseases such as atherosclerosis, hyperten-
sion and diabetes mellitus is indicated if the waist-to-hip
ratio exceeds 1,0 in men and 0,8 in women." Despite
their lower body mass, both the OP women (P =0,009)
and the OP men (P = 0,002) had significantly higher
waist-to-hip ratios than corresponding controls (Table
II). The odds that an OP man had a middle fat distribu-
tion was 8 times higher than the odds for a control man
(95% Cl: 1,037 - 61,731), whereas the odds for OP
women were 1,6 times higher (95% Cl: 0,751 - 3,538).
In women, upper body segment obesity is associated
with decreased sex hormone binding globulin levels, an
increase in the percentage of free testosterone and a
decrease in oestrogen.33 Conversely, elevated levels of
oestrone and both free and total oestradiol, and subnor-
mal levels of free testosterone and lutenising hormone,
which in combination represent a state of mild hypo-
gonadotrophic hypogonadism, have been described in
obese men." Whatever the underlying pathogenesis, this
novel finding suggests that OP should now be added to
the list of chronic degenerative diseases associated with
a middle fat distribution.
Risk factor analysis
The development of skeletal failure and OP fractures
depend on both peak adult bone mass and rate of bone
loss. Genetic facwrs are thought to have a strong influ-
ence on the attainment of peak bone mass.' An interest-
ing finding in our study was that the OP women had a
4,3 times greater chance (95% Cl: 1,729 - 10,920) of
having a positive family history of OP than the control
women (P = 0,02). No such difference was noted in
males, suggesting that the genetic predisposition to
develop OP was sex (females)-linked. A fair complexion,
assessed on the basis of hair/eye colour, was also found
to be a risk factor in women (P =0,009), with an OR of
3 in favour of the OP women (95% Cl: 1,314 - 6,879).
Exercise against gravitation stimulates new bone for-
mation and decreases the rate of bone 10ss.28 A direct
effect of muscle-pull on bone," as well as higher circu-
lating levels of calcitonin, have been proposed to explain
this finding. 36 This study revealed that OP men had a
significantly (P =0,008) greater chance of not currently
participating in exercise than control men. No difference
was found between the women.
It is well known that women who experience a pre-
mature menopause are at risk, but the roles of parity, age
at menarche and breast-feeding as risk factors are poorly
defined. 30 No difference was found between the two
groups of women regarding the number of pregnancies
or age at menopause (44,2 years for OP women and
45,5 years for control women (P =0,387). Thirteen per
cent of the OP women and 11 % of the control women
had not reached the menopause. These differences were
not statistically significant. However, whereas 47% of
OP women did not breast-feed and only 13% breast-fed
for more than 3 months, 42% of control women breast-
fed for more than 3 months and a mere 9% never
breast-fed at all. The OR that an OP woman did not
breast-feed her baby was 4 times higher (95% Cl: 1,545
- 12,581) than that for a control woman (P = 0,006). It
was previously believed that lactation resulted in a
severe negative calcium balance ('drainage effect') and
bone loss.'o More recent data suggest that long-term lac-
tation may in fact protect against bone loss because lac-
tation stimulates bone remodelling. 37 Our data would
support this hypothesis.
Women who smoke have lower serum oestrogen
levels, a lower body mass, undergo menopause at an
earlier age, and generally have a lower bone mass than
women who do not smoke.' All subjects in our study
decreased their smoking habits over the preceding
10 years. Significantly more OP men than control
men were current smokers (P = 0,01; OR 5,75; 95%
Cl: 1,425 - 32,256), while OP women with a previous
smoking history also ournumbered control women (P =
0,001; OR 5,38; 95% Cl: 2,481 - 11,627).
Conclusion
Since OP usually becomes manifest at a late stage, early
identification of those at risk is essential if rational pre-
vention regimens are to be implemented successfully.
Mass screening of BMD is expensive, impractical and
not recommended by leaders in the field, including the
National Osteoporosis Foundation of the USA.'
Although it is generally stated that the predictive value
of a risk factor analysis for OP is limited and in the order
of 40 - 60%,' we believe that this can be improved upon
as newer data become available (the calcium contro-
versy is a case in point), and if this information is
applied in the evaluation of specific patient populations.
The present study attempted to identify risk factors for
the development of OP in such a local population, and
these are summarised in Table Ill. Clearly the study
group was too small to give relative priority to these risk
factors or to assess ORs for various combinations of risk
factors. Moreover, given the clinical, biochemical and
histological heterogeneity of the OP syndrome,' it is to
be expected that risk factors at different ages, in differ-
ent ethnic groups and for different types of OP (spine v.
hip; high- v. Iow-turnover OP) could differ markedly.
Further studies are required if a scientific and cost-effec-
tive approach to ·the effective management of OP is to
be realised.
TABLE Ill.
Risk factors for the development of OP
Females
Family history of OP
Fair complexion
No breast-feeding
Males
Lack of exercise
Preference for salty food
Both sexes
Lower body weight
Lower height
Smoking history
High alcohol intake
Fat distribution around the waist
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Guidelines for the tnanagetnent ofasthtna in adults in
South Africa
Part 11. Acute asthma
STATEMENT BY A WORKING GROUP OF THE SOUTH AFRICAN PULMONOLOGY SOCIETY
The m.orbidity and m.ortality caused by asthm.a
can be attributed to three factors: underassess-
m.ent of severity, failure on the part of both
patients and their m.edical attendants to initiate
treatm.ent prom.ptly, and undertreatm.ent of
exacerbations; Moreover, m.ost exacerbations can
be prevented by use of appropriate long-term.
treatm.ent (S Aft MedJ 1992; 81: 319-322). The pre-
sent guidelines are for the care of acute asthm.a
('asthm.a attacks') and are intended to encourage a
uniform. approach to the m.anagem.ent of exacer-
bations, whether of rapid or gradual onset, m.ild or
severe. They have been developed on the basis of
the best available evidence on the efficacy and
safety of asthm.a drugs, and efforts have been
m.ade to ensure that recom.m.endations are cost-
effective and affordable, and m.ay with little m.odi-
fication be applied in all locations: the hom.e (as
initial self-m.anagem.ent), the clinic with m.odest
facilities, doctors' surgeries, emergency depart-
m.ents and hospitals. The guidelines stress (1)
assessm.ent of severity; (iz) recognition of risk; and
(ii1) stepwise treatm.ent based upon these assess-
m.ents. Prim.ary therapies are the repeated use of
high doses of [32-agonists and early introduction of
corticosteroids.
Specific goals of treatm.ent are to: (1) relieve
airway obstruction; (i1) relieve hypoxaem.ia;
(iiz) restore lung function to norm.al as rapidly as
possible by reducing airway irritability; (iv) pro-
vide a suitable plan to avoid future relapse; and
(v) provide a written plan of action to be followed
early in future attacks.
Sim.plified m.anagem.ent schem.es for different
locations are provided as addenda for ease of
reference.
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.Definition and general comment
Acute asthma (the 'acute asthma attack') is usually an
exacerbation of chronic asthma, and is characterised by
worsening shormess of breath, cough, wheeze and chest
tighmess, or combinations of these symptoms, often
with apparent non-responsiveness to usual bronchodila-
tor treatment. It may range from mild to life-threatening
and is always associated with a fall in expiratory airflow
measured as peak expiratory flow (PEF) rate or forced
expiratory volume in I second (FEV.). The latter serve
as more reliable indicators of severity of airflow obstruc-
tion than the severity of symptoms.
